Coty Announces Stéphane Delbos as New Chief Procurement Officer

Coty Announces Stéphane Delbos as New Chief Procurement Officer

Delbos brings nearly two decades senior industry experience, including over 10 years at Coty

NEW YORK–(BUSINESS WIRE)–
Coty Inc. (NYSE: COTY), one of the world’s leading beauty companies and the global leader in fragrances, today announced the promotion of Stéphane Delbos to Chief Procurement Officer (CPO), effective February 1, 2021.

Delbos, who joined Coty in 2010 as Global Sourcing Director, has been promoted from his current role as Senior Vice President (SVP) for Transformation, Indirect and Procurement Operations, where he has played an important role in driving forward Coty’s broader transformation agenda. Delbos will join Coty’s senior leadership team and report to Gordon von Bretten, Chief Transformation Officer.

Delbos is a respected senior procurement professional with over 18 years’ experience in the beauty and pharmaceutical industries. Prior to joining Coty, he held several local and global procurement positions at Pfizer and Ipsen.

Gordon von Bretten, Coty’s Chief Transformation Officer, said:

“Stéphane’s diverse experience and proven track record over 10 years at Coty make him a great addition to Coty’s senior leadership team. He has a deep understanding of how this company works and has been integral to progressing our financial transformation and successfully navigating the challenges of COVID-19. I look forward to continue working with him closely as we transform Coty into a true beauty powerhouse that’s stronger, more focused and set up for long-term profitable growth.”

In his new role, Delbos will be responsible for implementing Coty’s multi-year procurement strategy, which includes achieving a significant cost reduction target by FY23, reducing complexity and strengthening Coty’s new product pipeline with leading innovation from external suppliers. This forms an important element of Coty’s transformation program, announced in 2020.

The program is targeting a net reduction in costs of $600 million by the end of FY2023 and delivering more cost-effective and integrated operations. Coty reported strong progress towards these cost reduction targets during its Q1 earnings: delivering $80 million savings in the first quarter against a target of over $200 million by end of FY2021.

About Coty Inc.

Coty is one of the world’s largest beauty companies with an iconic portfolio of brands across fragrance, color cosmetics, and skin and body care. Coty is the global leader in fragrance and number three in color cosmetics. Coty’s products are sold in over 150 countries around the world. Coty and its brands are committed to a range of social causes as well as seeking to minimize its impact on the environment. For additional information about Coty Inc., please visit www.coty.com.

Forward Looking Statements

Certain statements in this release are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect the Company’s current views with respect to, among other things, the Company’s future operations and strategy (including the expected implementation and related impact of its strategic priorities), and ongoing and future cost efficiency, optimization and restructuring initiatives and programs (including their expected timing, implementation, cost and related impact). These forward-looking statements are generally identified by words or phrases, such as “anticipate”, “are going to”, “estimate”, “plan”, “project”, “expect”, “believe”, “intend”, “foresee”, “forecast”, “will”, “may”, “should”, “outlook”, “continue”, “temporary”, “target”, “aim”, “potential”, “goal” and similar words or phrases. These statements are based on certain assumptions and estimates that we consider reasonable, but are subject to a number of risks and uncertainties, many of which are beyond our control, which could cause actual events or results (including our financial condition, results of operations, cash flows and prospects) to differ materially from such statements, including risks and uncertainties relating to:

  • the Company’s ability to successfully implement its multi-year Transformation Plan, including the consolidation of its global fragrance manufacturing operations and supply chain optimization plans, as well as its initiatives to further reduce the Company’s cost base, and to develop and achieve its global business strategies (including mix management, select price increases, more disciplined promotions, and foregoing low value sales), compete effectively in the beauty industry, achieve the benefits contemplated by its strategic initiatives (including revenue growth, cost control, gross margin growth and debt deleveraging) and successfully implement its strategic priorities (including innovation performance in prestige and mass channels, strengthening its positions in core markets, accelerating its digital and e-commerce capabilities, building on its skincare portfolio, and expanding its presence in China) in each case within the expected time frame or at all;
  • the impact of COVID-19 (or future similar events), including demand for the Company’s products, illness, quarantines, government actions, facility closures, store closures or other restrictions in connection with the COVID-19 pandemic, and the extent and duration thereof, related impact on the Company’s ability to meet customer needs and on the ability of third parties on which the Company relies, including its suppliers, customers, contract manufacturers, distributors, contractors, commercial banks and joint-venture partners, to meet their obligations to the Company, in particular, collections from customers, the extent that government funding and reimbursement programs in connection with COVID-19 are available to the Company, and the ability to successfully implement measures to respond to such impacts;
  • managerial, transformational, operational, regulatory, legal and financial risks, including diversion of management attention to and management of cash flows, expenses and costs associated with the Company’s response to COVID-19, its multi-year Transformation Plan, the transition services related to the Wella Business, the integration of acquisitions (including the strategic partnerships with Kylie Jenner and Kim Kardashian West), and future strategic initiatives, and, in particular, the Company’s ability to manage and execute many initiatives simultaneously including any resulting complexity, employee attrition or diversion of resources;
  • global political and/or economic uncertainties, disruptions or major regulatory or policy changes, and/or the enforcement thereof that affect the Company’s business, financial performance, operations or products, including the impact of Brexit (and related business or market disruption), the current U.S. administration and recent election, changes in the U.S. tax code, and recent changes and future changes in tariffs, retaliatory or trade protection measures, trade policies and other international trade regulations in the U.S., the European Union and Asia and in other regions where the Company operates;
  • disruptions in operations, sales and in other areas, including due to disruptions in the Company’s supply chain, restructurings and other business alignment activities, the completion of the Wella Transaction and related carve-out and transition activities, manufacturing or information technology systems, labor disputes, extreme weather and natural disasters, impact from COVID-19 or similar global public health events and the impact of such disruptions on the Company’s ability to generate profits, stabilize or grow revenues or cash flows, comply with their contractual obligations and accurately forecast demand and supply needs and/or future results;
  • restrictions imposed on the Company through its license agreements, credit facilities and senior unsecured bonds or other material contracts, its ability to generate cash flow to repay, refinance or recapitalize debt and otherwise comply with its debt instruments, and changes in the manner in which the Company finances its debt and future capital needs;
  • the number, type, outcomes (by judgment, order or settlement) and costs of current or future legal, compliance, tax, regulatory or administrative proceedings, investigations and/or litigation, including litigation relating to the tender offer by Cottage Holdco B.V. (the “Cottage Tender Offer”), and product liability cases (including asbestos); and
  • other factors described elsewhere in this document and in documents that the Company files with the SEC from time to time.

When used herein, the term “includes” and “including” means, unless the context otherwise indicates, “including without limitation”. More information about potential risks and uncertainties that could affect the Company’s business and financial results is included under the heading “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the Company’s Annual Report on Form 10-K for the year ended June 30, 2020 and other periodic reports the Company has filed and may file with the SEC from time to time.

All forward-looking statements made in this release are qualified by these cautionary statements. These forward-looking statements are made only as of the date of this release, and the Company does not undertake any obligation, other than as may be required by applicable law, to update or revise any forward-looking or cautionary statements to reflect changes in assumptions, the occurrence of events, unanticipated or otherwise, or changes in future operating results over time or otherwise.

Investor Relations

Olga Levinzon, +1 212 389-7733 / [email protected]

Media

Antonia Werther, +31 621 394495 / [email protected]

KEYWORDS: United States North America New York

INDUSTRY KEYWORDS: Cosmetics Retail Other Retail Fashion

MEDIA:

Patria Investments Limited Announces Pricing of Initial Public Offering

PR Newswire

GRAND CAYMAN, Cayman Islands, Jan. 22, 2021 /PRNewswire/ — Patria Investments Limited (“Patria”), one of the leading private markets investment firms in Latin America, today announced the pricing of its initial public offering of 30,098,824 Class A common shares, consisting of 16,650,000 Class A common shares offered by Patria and 13,448,824 Class A common shares offered by the selling shareholder, Blackstone PAT Holdings IV, L.L.C., pursuant to a registration statement on Form F-1 filed with the U.S. Securities and Exchange Commission (“SEC”) at a public offering price of $17.00 per share. The Class A common shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “PAX” today and the offering is expected to close on January 26, 2021, subject to customary closing conditions.

In connection with the offering, Patria and the selling shareholder have granted the underwriters a 30-day option to purchase up to an additional 4,514,823 Class A common shares at the initial public offering price, less underwriting discounts and commissions.

Patria intends to use the net proceeds from the offering to fund capital commitments to its existing and new funds, for the expansion of its operations through acquisitions of asset managers, portfolios and distribution channels, and for general corporate purposes.

The offering is being made through an underwriting group led by J.P. Morgan, BofA Securities and Credit Suisse, who are acting as global coordinators, Goldman Sachs & Co. LLC, who is acting as joint bookrunner, and Bradesco BBI, BTG Pactual, Itaú BBA, Keefe, Bruyette & Woods, Inc., Santander and XP Investments US, LLC, who are acting as co-managers.

The offering will be made only by means of a prospectus. When available, copies of the final prospectus may be obtained by contacting: J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by telephone at 1-866 803 9204, or by email at [email protected]; BofA Securities, Inc.,  NC1-004-03-43 200 North College Street, 3rd floor Charlotte NC  28255-0001, Attn: Prospectus Department or by email at [email protected]; Credit Suisse Securities (USA) LLC, Attention: Prospectus Department, 6933 Louis Stephens Drive, Morrisville, North Carolina 27560, United States, or by telephone at 1-800-221-1037 or by email at [email protected].

A registration statement on Form F-1 relating to these securities has been filed with, and declared effective by, the SEC. Copies of the registration statement can be accessed through the SEC’s website at www.sec.gov. This press release does not constitute an offer to sell or a solicitation of an offer to buy the securities described herein, nor will there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Contact:


Luis Fernando E. Lopes

21 Grosvenor Pl, Belgravia  London SW1X 7EA, UK
t +44 79 1917 3408; +44 7584 129242
[email protected]


Andre Medina

18 Forum Lane, 3rd floor, Camana Bay  PO Box 757 | KY1-9006, Grand Cayman, Cayman Islands
t +1 345 640 4904
[email protected]

 

Cision View original content:http://www.prnewswire.com/news-releases/patria-investments-limited-announces-pricing-of-initial-public-offering-301213203.html

SOURCE Patria Investments Limited

Liberty Health Sciences Continues Expansion in Florida’s Southwest with Opening of its 29th store in Fort Meyers

PR Newswire

TORONTO, Jan. 22, 2021 /PRNewswire/ – Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) www.libertyhealthsciences.com (“Liberty” or the “Company”), a Florida licensed medical marijuana provider of high-quality cannabis, announced today that it has opened its 29th retail location in Fort Meyers, Florida.

Liberty Fort Meyers, located at 8951 Daniels Parkway, is a spacious facility that provides ample parking and a well-trained staff to assist patients and answer questions about products and review doctor recommendations. The new dispensary carries the full Liberty Health Sciences suite of cannabis brands that are tailored to provide patients with the best quality-of-life wellness products. The dispensary’s operating hours are Monday through Friday, 10 a.m. to 7 p.m., Saturday, 10 a.m. to 5 p.m., and Sunday, 12 p.m. to 5 p.m.

“Liberty will be opening new locations throughout the year to continually provide patient-driven customer service and access to the broadest assortment of premium medical cannabis products and devices across the state,” said George Gremse, interim CEO of Liberty Health Sciences. “In February we will open a store in Ft. Pierce, St. Lucie County to increase our presence on the east coast of the state and Port Charlotte in Charlotte County to serve the southwest. In March we plan to open locations in the Florida panhandle in Mary Ester and central Florida in the city of Sebring located in Highlands County. 

Liberty plans to open nine more dispensaries through the spring and summer of this year for a total of 42 locations throughout Florida, subject to approval from the Florida Department of Health.

Patients may place an order online at www.libertyhealthsciences.com for in-store pick-up or delivery.

About Liberty Health Sciences Inc.

Liberty Health Sciences is an integrated “seed-to-sale” company that provides medical marijuana products to patients throughout the State of Florida. All its cultivation and processing is done at its 387-acre Gainesville, Florida facility. Patients purchase products either through Liberty’s statewide network of dispensaries or via company provided home delivery. Liberty’s stock trades in the United States on the OTCQX market under the symbol LHSIF and on the Canadian Securities Exchange under the symbol LHS. For more information, please visit: www.libertyhealthsciences.com 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: This press release contains certain forward-looking statements within the meaning of applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “believe”, “plan”, “intend” or the negative of these terms and similar expressions. Forward-looking statements in this news release include, but are not limited to, expectations related to the Company’s production capabilities, expectations concerning the receipt of all necessary approvals from the Florida Department of Health, expectations concerning the opening of new dispensaries and the expansion of its greenhouse space, and the Company’s future expansion and growth strategies. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving medical marijuana; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favorable terms; the medical marijuana industry in the United States generally, income tax and regulatory matters; the ability of Liberty to implement its business strategies; competition; crop failure; currency and interest rate fluctuations and other risks. Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions, or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/liberty-health-sciences-continues-expansion-in-floridas-southwest-with-opening-of-its-29th-store-in-fort-meyers-301213166.html

SOURCE Liberty Health Sciences Inc.

IIROC Trading Halt – ELEF

Canada NewsWire

TORONTO, Jan. 22, 2021 /CNW/ – The following issues have been halted by IIROC:

Company: Silver Elephant Mining Corp.

TSX Symbol: ELEF

All Issues: Yes

Reason: Pending News

Halt Time (ET): 8:00 AM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) – Halts/Resumptions

Precigen Announces Pricing of $112.5 Million Public Offering of Common Stock

PR Newswire

GERMANTOWN, Md., Jan. 22, 2021 /PRNewswire/ — Precigen, Inc. (Nasdaq: PGEN) today announced the pricing of an underwritten public offering of 15,000,000 shares of its common stock at a public offering price of $7.50 per share. Precigen has also granted the underwriters a 30-day option to purchase up to an additional 2,250,000 shares of its common stock. Gross proceeds from the offering, before deducting underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $112.5 million, excluding any exercise of the underwriters’ option. The offering is expected to close on January 26, 2021, subject to customary closing conditions.

Wells Fargo Securities and Stifel are acting as joint book-running managers for the offering with JMP Securities acting as lead manager and H.C. Wainwright & Co. acting as co-manager.

Precigen intends to use the net proceeds from the offering to fund the development of clinical and preclinical product candidates and for working capital and other general corporate purposes.

The public offering is being made pursuant to a shelf registration statement on Form S-3 that was previously filed with the Securities and Exchange Commission (SEC) and became effective on July 2, 2020. The final prospectus supplement and accompanying base prospectus relating to and describing the terms of the offering will be filed with the SEC and will be available on the SEC’s website at www.sec.gov. Copies of the final prospectus supplement, when available, and accompanying base prospectus relating to the offering may be obtained from Wells Fargo Securities, LLC, Attention: Equity Syndicate Department, 500 West 33rd Street, New York, NY 10001,  by telephone at (800) 326-5897, or by email at [email protected]; or Stifel, Nicolaus & Company, Incorporated, Attention: Syndicate, One Montgomery Street, Suite 3700, San Francisco, California 94104, by telephone at (415) 364-2720, or by email at [email protected]

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Precigen: Advancing Medicine with Precision
Precigen (Nasdaq: PGEN) is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in our core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. Our technologies are designed to enable us to find innovative solutions for affordable biotherapeutics in a controlled manner. Precigen operates as an innovation engine progressing a preclinical and clinical pipeline of well-differentiated unique therapies toward clinical proof-of-concept and commercialization.

Cautionary Statement Regarding Forward-Looking Statements
Some of the statements made in this press release are forward-looking statements. These forward-looking statements are based upon Precigen’s current expectations and projections about future events and generally relate to the proposed public offering. Various factors may cause differences between Precigen’s expectations and actual results, including risks and uncertainties associated with market conditions and the satisfaction of customary closing conditions related to the proposed offering. For further information on potential risks and uncertainties, and other important factors, any of which could cause Precigen’s actual results to differ from those contained in the forward-looking statements, see the section entitled “Risk Factors” in Precigen’s most recent Annual Report on Form 10-K and subsequent reports filed with the Securities and Exchange Commission.

For more information, contact:


Investor Contact:


Steven Harasym

Vice President, Investor Relations

Tel: +1 (301) 556-9850



[email protected]
 


Media Contact:


Glenn Silver

Lazar-FINN Partners



[email protected]
 

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/precigen-announces-pricing-of-112-5-million-public-offering-of-common-stock-301213003.html

SOURCE Precigen, Inc.

Wynn Las Vegas Achieves Health Security Verification From Sharecare and Forbes Travel Guide

PR Newswire

LAS VEGAS, Jan. 22, 2021 /PRNewswire/ — Wynn Las Vegas is among the first resorts in the world to become Sharecare Health Security VERIFIED™ with Forbes Travel Guide. The comprehensive facility verification helps ensure that guests can book with confidence at a resort that has consistent and robust health safety procedures in place.

Wynn has worked closely with a team of public health professionals to create a transparent health and safety program.

“We have worked tirelessly to develop rigorous health and safety practices to ensure that our guests feel safe when visiting,” said Marilyn Spiegel, president of Wynn Las Vegas and Encore.  “This verification is a testament to our efforts as we continue to offer our guests the latest health safety advancements and the very best five-star resort experience.”

The Sharecare Health Security verification comes with an easily identifiable “seal of approval” – the Sharecare VERIFIED™ with Forbes Travel Guide badge – based on a hotel’s compliance with expert-validated best practices that minimize the risk and impact of COVID-19 and potential future public health events.

Developed by Forbes Travel Guide, the global authority on hospitality excellence, and digital health industry leader Sharecare, the comprehensive verification covers more than 360 standards across health and hygiene protocols, cleaning products and procedures, ventilation, physical distancing, the guest experience, and health safety communication with guests and employees. Hotels are required to verify their health protocols on an ongoing basis to ensure continued compliance with the most up-to-date global health standards.

“The pandemic has made it clear that hotels and resorts must, first and foremost, assure guests of their safety,” said Filip Boyen, CEO of Forbes Travel Guide. “By becoming VERIFIED™, Wynn Las Vegas has demonstrated its commitment to creating a culture of accountability and following global best practices to heighten health security, certified by a third party.”

Wynn Las Vegas has worked closely with a team of leading medical and public-health professionals to create its clear and transparent Health and Safety program based on the most effective practices available.

The resort’s full Health and Safety plan is available at



https://www.wynnlasvegas.com/health-and-safety
.

Wynn Las Vegas recently opened an onsite COVID-19 vaccination center in conjunction with University Medical Center.  This unique partnership was formed to increase distribution of the vaccine throughout Las Vegas, and to assist in the state’s recovery from the pandemic.  In the coming weeks, the resort will debut an onsite COVID-19 testing lab that will offer PRC testing, known as the “gold standard” of tests for its accuracy in detecting the virus,  to employees, hotel guests, and meetings and convention groups. 

For a complete list of hotels and resorts that currently are Sharecare Health Security VERIFIED™ with Forbes Travel Guide, please visit www.forbestravelguide.com/verified.

About Wynn Resorts COVID-19 Relief Efforts
Wynn Resorts (NASDAQ: WYNN) is committed to protecting our employees, working for the health and safety of our guests, and taking care of our communities impacted by COVID-19 with relief efforts that fill financial and supply chain gaps where they matter most. The donation and volunteer strategies follow an extensive financial protection plan implemented by Wynn Resorts CEO Matt Maddox that began with a $250 million investment that ensured all 15,000 Wynn employees in North America received their full wage during the government-mandated shutdown.

To provide relief to first responders and protection to those suffering the financial impact of the crisis, the Company procured and donated more than $3 million worth of financial aid, personal protective equipment, food and prepared meals, and essential cleaning and hygiene supplies to dozens of health care facilities and local nonprofit organizations throughout Las Vegas and Greater Boston. In May 2020, Wynn Las Vegas began providing all employees with direct access to reliable and accurate COVID-19 tests on-site at no cost; and in early 2021 will debut a custom-built state-of-the-art COVID-19 testing lab and mobile health app available to resort guests.

About Forbes Travel Guide 
Forbes Travel Guide is the only independent, global rating system for luxury hotels, restaurants and spas. Started as Mobil Travel Guide in 1958, the company created the first Five-Star rating system in the United States. Today, Forbes Travel Guide’s incognito inspectors travel the world, evaluating properties based on up to 900 rigorous, objective standards. Forbes Travel Guide also supports the hospitality industry and other service-oriented businesses such as luxury residential, healthcare and private clubs with bespoke training solutions, evaluation services and the creation of custom service standards. For more information, please visit partner.forbestravelguide.com.  

About Sharecare 
Sharecare is the leading digital health company that helps people – no matter where they are in their health journey – unify and manage all their health in one place. Our comprehensive and data-driven virtual health platform is designed to help people, providers, employers, health plans, government organizations, and communities optimize individual and population-wide well-being by driving positive behavior change. Driven by our philosophy that we are all together better, at Sharecare, we are committed to supporting each individual through the lens of their personal health and making high-quality care more accessible and affordable for everyone. To learn more, visit www.sharecare.com.  

MEDIA CONTACT:
Deanna Pettit-Irestone
702-770-2120/ [email protected] 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/wynn-las-vegas-achieves-health-security-verification-from-sharecare-and-forbes-travel-guide-301213073.html

SOURCE Wynn Las Vegas

IIROC Trading Halt – COIN

Canada NewsWire

VANCOUVER, BC, Jan. 22, 2021 /CNW/ – The following issues have been halted by IIROC:

Company: Coin Hodl Inc.

TSX-Venture Symbol: COIN

All Issues: Yes

Reason: At the Request of the Company Pending News

Halt Time (ET): 7:52 AM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) – Halts/Resumptions

Walgreens Completes More Than 1 Million COVID-19 Vaccinations

Walgreens Completes More Than 1 Million COVID-19 Vaccinations

Company remains on track to complete first vaccine doses in skilled nursing facilities by Jan. 25

DEERFIELD, Ill.–(BUSINESS WIRE)–
Walgreens has administered more than 1 million COVID-19 vaccinations across long-term care facilities and other vulnerable populations identified as part of state and jurisdiction distribution plans. The company also remains on track to complete the administration of COVID-19 vaccine first doses in skilled nursing facilities by Monday, Jan. 25.

Walgreens began administering COVID-19 vaccinations as part of the Centers for Disease Control and Prevention (CDC) Pharmacy Partnership for Long-Term Care Program on Dec. 21 and has continued to expand vaccine efforts according to state and jurisdiction distribution plans.

“Thanks to the dedication of tens of thousands of Walgreens pharmacy team members, we have been able to provide 1 million COVID-19 vaccinations to those who need them most in just one month,” said John Standley, president, Walgreens. “This unprecedented effort has not been without challenges, but as federal, state and local jurisdictions continue to advance their prioritization and distribution plans, we have been able to rapidly expand vaccine access to our nation’s most vulnerable populations and help our communities begin to emerge from this pandemic.”

Walgreens is also providing COVID-19 vaccinations to additional vulnerable populations as determined by states and jurisdictions. The initial supply of vaccine is extremely limited and available to eligible individuals by appointment only at designated Walgreens stores. COVID-19 vaccines are not available to the general public. Eligible individuals vary based on state and jurisdiction guidelines and may include healthcare workers, people ages 65 and older and individuals with pre-existing conditions. Walgreens will not be providing vaccinations on a walk-in basis during Phase 1.

Walgreens continues to follow all state and federal COVID-19 vaccination reporting protocols. Information and data regarding Walgreens long-term care facility vaccination efforts are available here with updates provided at approximately 4 p.m. CT on weekdays. More information on Walgreens efforts to support communities during the COVID-19 pandemic is available here.

Additional imagery, b-roll and multimedia assets are available on the Walgreens newsroom.

About Walgreens

Walgreens (www.walgreens.com) is included in the Retail Pharmacy USA Division of Walgreens Boots Alliance, Inc. (Nasdaq: WBA), a global leader in retail and wholesale pharmacy. As America’s most loved pharmacy, health and beauty company, Walgreens purpose is to champion the health and wellbeing of every community in America. Operating more than 9,000 retail locations across America, Puerto Rico and the U.S. Virgin Islands, Walgreens is proud to be a neighborhood health destination serving approximately 8 million customers each day. Walgreens pharmacists play a critical role in the U.S. healthcare system by providing a wide range of pharmacy and healthcare services. To best meet the needs of customers and patients, Walgreens offers a true omnichannel experience, with platforms bringing together physical and digital, supported by the latest technology to deliver high-quality products and services in local communities nationwide.

Kelli Teno

[email protected]

KEYWORDS: United States North America Illinois

INDUSTRY KEYWORDS: Nursing Infectious Diseases Other Retail Specialty Managed Care Health Pharmaceutical General Health Retail

MEDIA:

Logo
Logo

Sierra Bancorp Declares Quarterly Cash Dividend

Sierra Bancorp Declares Quarterly Cash Dividend

PORTERVILLE, Calif.–(BUSINESS WIRE)–
Sierra Bancorp (Nasdaq: BSRR), parent of Bank of the Sierra, today announced that its Board of Directors has declared a regular quarterly cash dividend of $0.21 per share. This represents an increase of $0.01 per share, or 5%, relative to the dividend paid last quarter. The dividend was approved subsequent to the Board’s review of the Company’s financial performance and capital for the quarter ended December 31, 2020 and will be paid on February 12, 2021 to shareholders of record as of January 29, 2021. Counting dividends paid by Bank of the Sierra prior to the formation of Sierra Bancorp the Company has paid regular cash dividends to shareholders every year since 1987, comprised of annual dividends through 1998 and quarterly dividends thereafter. The dividend noted in today’s announcement marks the Company’s 88th consecutive quarterly cash dividend.

Sierra Bancorp is the holding company for Bank of the Sierra (www.bankofthesierra.com), which is in its 44th year of operations and is the largest independent bank headquartered in the South San Joaquin Valley. Bank of the Sierra is a community-centric regional bank, which offers a broad range of retail and commercial banking services through full-service branches located within the counties of Tulare, Kern, Kings, Fresno, Los Angeles, Ventura, San Luis Obispo and Santa Barbara. The Bank also maintains an online branch, and provides specialized lending services through an agricultural credit center, an SBA center, and a loan production office in Rocklin, California. In 2020, Bank of the Sierra was recognized as one of the strongest and top-performing community banks in the country with a 5-star rating from Bauer Financial.

Forward-Looking Statements

The statements contained in this release that are not historical facts are forward-looking statements based on management’s current expectations and beliefs concerning future developments and their potential effects on the Company. Readers are cautioned not to unduly rely on forward-looking statements. Actual results may differ from those projected. These forward-looking statements involve risks and uncertainties including but not limited to the Company’s ability to maintain dividend payments or increase dividend payouts to shareholders, the Company’s ability to generate adequate financial results, our borrowers’ actual payment performance as loan deferrals related to the COVID-19 pandemic expire, changes to statutes, regulations, or regulatory policies or practices as a result of, or in response to COVID-19, including the potential adverse impact of loan modifications and payment deferrals implemented consistent with recent regulatory guidance, the health of the national and local economies, the Company’s ability to attract and retain skilled employees, customers’ service expectations, the Company’s ability to successfully deploy new technology, the success of acquisitions and branch expansion, changes in interest rates, loan portfolio performance, and other factors detailed in the Company’s SEC filings, including the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of the Company’s most recent Form 10-K and Form 10-Q. Sierra Bancorp undertakes no responsibility to update or revise any forward-looking statements.

Category: Financial

Source: Sierra Bancorp

Kevin McPhaill, President/Chief Executive Officer

Phone: (559) 782-4900 or (888) 454-BANK

Website Address: www.sierrabancorp.com

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Banking Professional Services Finance

MEDIA:

Logo
Logo

UNCF & 3M Launch New Scholarship Program for St. Paul, MN Students to Attend HBCUs

Eligible students will receive up to $25k and professional development training

WASHINGTON, Jan. 22, 2021 (GLOBE NEWSWIRE) — A $5 million gift from 3M to UNCF (United Negro College Fund) will create a new multi-year need-based scholarship program to support more than 100 Saint Paul, MN, students as they embark on STEM-related studies at Historically Black Colleges and Universities or at Florida International University (FIU). The UNCF 3M Science. Applied to Life. TM  Scholarship Program is open to underrepresented minority high school seniors attending Saint Paul Public Schools or charter schools serving St. Paul students and current first-year college students attending an HBCU or FIU who graduated from Saint Paul Public Schools or Saint Paul-serving charter schools. Over the next four years, up to 29 students majoring in STEM-related studies will be selected to receive scholarships and will be eligible to receive up to $25,000 over the four-year period, with funding available for emergency aid.

During the summer months, scholarship recipients will engage with 3M, learning first-hand from executives about their career journey, experiences and roles within the company. The intent is to create connections between UNCF scholars and 3M employee mentors.

“UNCF is excited to work with 3M to launch this new opportunity for students in the Twin Cities who plan to attend our nation’s HBCUs,” said Dr. Michael Lomax, UNCF president and CEO. “The scholarship and career development will change the lives of many students who may not have the financial means to further their education after earning a high school diploma. With this support, more students from Saint Paul will have the opportunity to earn their STEM degrees and begin meaningful careers in the 21st century workforce.”

Twenty-five percent of STEM degrees earned by African American graduates are earned at HBCUs. HBCUs graduated 46% of Black women who earned degrees in STEM disciplines between 1995 and 2004. Eight HBCUs were among the top 20 institutions to award the most science and engineering bachelor’s degrees to Black graduates from 2008-2012. HBCUs are the institution of origin among almost 30% of Black graduates of science and engineering doctorate programs.

Even with recent growth in the field, statistics regarding African Americans in STEM fields show their white and non-Black counterparts outpace them in key positions. Black and white students pursue STEM degrees at similar rates, but Black students in STEM fields do not attain comparable representation as it relates to their degree attainment. This new partnership with UNCF and 3M aims to bolster more underrepresented students into STEM professions.

“As part of our commitment to advancing social justice, we’re incredibly proud to partner with Saint Paul Public Schools and UNCF to provide STEM scholarships for students to attend Historically Black Colleges and Universities,” said 3M’s Chief Equity Officer, James Momon. “This collaboration is one of many milestones in our efforts toward creating greater equity for underrepresented populations.”

This partnership with UNCF is one part of 3M’s $50 million commitment to address racial opportunity gaps in STEM and Skilled Trades education. The company seeks to leverage its full capabilities, including philanthropy, to support more equitable outcomes for marginalized populations.

“Saint Paul Public Schools is grateful to 3M and UNCF for providing this opportunity to our high school graduates who aspire to pursue a STEM career at HBCUs,” said Superintendent Joe Gothard. “These scholarships will open doors that may not otherwise be available to our students and set them on a path to success in college and beyond.”

Scholarship applications are due by May 10, 2021. Scholarships will be awarded and administered by UNCF. Recipients will be notified by August 2021. Visit UNCF.org/3MScholarship to apply.

###

About UNCF
UNCF (United Negro College Fund) is the nation’s largest and most effective minority education organization. To serve youth, the community and the nation, UNCF supports students’ education and development through scholarships and other programs, strengthens its 37 member colleges and universities, and advocates for the importance of minority education and college readiness. UNCF institutions and other historically Black colleges and universities are highly effective, awarding nearly 20 percent of African American baccalaureate degrees. Today, UNCF supports more than 60,000 students at more than 1,100 colleges and universities across the country. Its logo features the UNCF torch of leadership in education and its widely recognized motto, “A mind is a terrible thing to waste.”® Learn more at UNCF.org, or for continuous updates and news, follow UNCF on Twitter at @UNCF.

About 3M 
At 3M (NYSE: MMM), we apply science in collaborative ways to improve lives daily as our employees connect with customers all around the world. Learn more about 3M’s creative solutions to global challenges at www.3M.com or on Twitter @3M or @3MNews

About Saint Paul Public Schools

Saint Paul Public Schools (SSPS) is one of Minnesota’s largest school districts with more than 36,000 students. Highly trained and deeply dedicated staff, cutting-edge academic programs, and strong community support are among the district’s hallmarks. Our student population is diverse, with students who speak more than 125 languages and dialects. Our Mission: Inspire students to think critically, pursue their dreams and change the world.



Khalilah Long
United Negro College Fund, Inc. (UNCF)
301.633.3928
[email protected]